Microsoft and our third-party vendors use cookies to store and access information such as unique IDs to deliver, maintain and ...

Madeleine R. Heldman, MD, MS, discusses managing cytomegalovirus, including advances in CMV assessment and antiviral and immune strategies.

The pipeline features several drugs, which are being investigated across different phases of development; 60% of the drug ...

Shares of biotech company Sarepta Therapeutics (NASDAQ:SRPT) fell 10.8% in the afternoon session after RBC analyst Brian ...

Trinity Biotech (NASDAQ:TRIB – Get Free Report) will likely be announcing its earnings results before the market opens on ...

COPENHAGEN, Denmark, April 1, 2025 - Evaxion Biotech A/S (NASDAQ: EVAX) (“Evaxion”), a clinical-stage TechBio company specializing in developing AI-Immunology™ powered vaccines, provides business ...

The patient died of acute liver failure; the maker of the gene therapy noted that the patient also had a recent ...

What makes this new study different is the duration and depth of analysis. The liver was fully vascularized and remained ...

Penn Vet researchers show that the immune system can recognize and control the latent stage of the parasite Toxoplasma gondii ...

The frustrating part is that you can't predict how long it will take' says Frenchman, who has yet to race in 2025 ...

Most humans have long-lived infections in various tissues—including in the nervous system—that typically do not result in ...

Sarepta Therapeutics announced that a patient with Duchenne muscular dystrophy who received Elevidys (delandistrogene moxeparvovec-rokl) died following treatment.